Clinical Trial Update: Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor [NA]

View source ↗

Summary

This clinical trial update reports on exploring molecular biomarkers associated with Lutetium-177 DOTATATE therapy in patients with midgut neuroendocrine tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Midgut Neuroendocrine Tumor

Drugs mentioned

• Lutetium-177 dotatate (Lutetium-177 dotatate)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Midgut Neuroendocrine Tumors | NA | Status: COMPLETED